ES2062041T3 - Composicion hemostatica de pasta de colageno. - Google Patents

Composicion hemostatica de pasta de colageno.

Info

Publication number
ES2062041T3
ES2062041T3 ES89312777T ES89312777T ES2062041T3 ES 2062041 T3 ES2062041 T3 ES 2062041T3 ES 89312777 T ES89312777 T ES 89312777T ES 89312777 T ES89312777 T ES 89312777T ES 2062041 T3 ES2062041 T3 ES 2062041T3
Authority
ES
Spain
Prior art keywords
hemostatic
collagen
collagen paste
hemostatic composition
paste
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89312777T
Other languages
English (en)
Inventor
Lowell Saferstein
Stephen Jeffrey Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Johnson and Johnson Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Medical Inc filed Critical Johnson and Johnson Medical Inc
Application granted granted Critical
Publication of ES2062041T3 publication Critical patent/ES2062041T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

UN COMPUESTO DE PASTA DE COLAGENO HEMOSTATICO QUE COMPRENDE UNA MEZCLA, CON UNA PROPORCION EN PESO DE LA COMPOSICION TOTAL DEL 2 AL 30 % DE POLVO DE COLAGENO RETICULADO DE TAMAÑO DE LA PARTICULA RETICULAR DE 10 A 100 Y UN 30 A UN 98 % DE AGUA O DE UNA SOLUCION SALINA ACUOSA Y COMPUESTOS DE PASTA HEMOSTATICA QUE TAMBIEN COMPRENDEN UNA CANTIDAD INCREMENTO HEMOSTATICO DE TROMBINA, ASI COMO METODOS DE REALIZAR Y UTILIZAR ESTOS COMPUESTOS DE PASTA DE COLAGENO HEMOSTATICO
ES89312777T 1988-12-08 1989-12-07 Composicion hemostatica de pasta de colageno. Expired - Lifetime ES2062041T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/282,224 US4891359A (en) 1988-12-08 1988-12-08 Hemostatic collagen paste composition

Publications (1)

Publication Number Publication Date
ES2062041T3 true ES2062041T3 (es) 1994-12-16

Family

ID=23080569

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89312777T Expired - Lifetime ES2062041T3 (es) 1988-12-08 1989-12-07 Composicion hemostatica de pasta de colageno.

Country Status (10)

Country Link
US (1) US4891359A (es)
EP (1) EP0372966B1 (es)
JP (1) JP3195335B2 (es)
AT (1) ATE103187T1 (es)
AU (1) AU623456B2 (es)
CA (1) CA2004739C (es)
DE (1) DE68914110T2 (es)
ES (1) ES2062041T3 (es)
IE (1) IE62927B1 (es)
ZA (1) ZA899372B (es)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466383A1 (en) * 1990-07-09 1992-01-15 BAUSCH & LOMB INCORPORATED A collagen medical adhesive and its uses
US6350274B1 (en) 1992-05-11 2002-02-26 Regen Biologics, Inc. Soft tissue closure systems
US5326350A (en) * 1992-05-11 1994-07-05 Li Shu Tung Soft tissue closure systems
US5868778A (en) * 1995-10-27 1999-02-09 Vascular Solutions, Inc. Vascular sealing apparatus and method
CA2175203A1 (en) * 1993-11-03 1995-05-11 Thaddeus P. Pruss Hemostatic patch
US6302898B1 (en) 1994-06-24 2001-10-16 Advanced Closure Systems, Inc. Devices for sealing punctures in body vessels
US6033401A (en) 1997-03-12 2000-03-07 Advanced Closure Systems, Inc. Vascular sealing device with microwave antenna
US5562946A (en) * 1994-11-02 1996-10-08 Tissue Engineering, Inc. Apparatus and method for spinning and processing collagen fiber
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5709934A (en) * 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
WO1996040033A1 (en) * 1995-06-07 1996-12-19 Clarion Pharmaceuticals Inc. Non-biological patch for hemostasis
US5911942A (en) * 1995-11-02 1999-06-15 Tissue Engineering, Inc. Method for spinning and processing collagen fiber
CZ318998A3 (cs) 1996-04-04 1999-09-15 Baxter Aktiengesellschaft Hemostatická houba na bázi kolagenu, způsob její přípravy, kryt na ránu a kit k přípravě tohoto krytu
US6927287B1 (en) * 1996-06-03 2005-08-09 United States Surgical Corporation Nucleic acid encoding extracellular matrix protein or fragment thereof
US6492508B1 (en) * 1996-06-03 2002-12-10 United States Surgical Corp. A Division Of Tyco Healthcare Group Nucleic acids encoding extracellular matrix proteins
SK22499A3 (en) * 1996-08-23 1999-10-08 Cook Biotech Inc Graft prosthesis, materials and methods
US6666892B2 (en) * 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US8716227B2 (en) * 1996-08-23 2014-05-06 Cook Biotech Incorporated Graft prosthesis, materials and methods
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US6743248B2 (en) 1996-12-18 2004-06-01 Neomend, Inc. Pretreatment method for enhancing tissue adhesion
AU716137B2 (en) * 1997-01-16 2000-02-17 Cohesion Corporation Lyophilized collagen-based biomaterials, process of preparation and uses thereof
US6733515B1 (en) 1997-03-12 2004-05-11 Neomend, Inc. Universal introducer
US20030191496A1 (en) * 1997-03-12 2003-10-09 Neomend, Inc. Vascular sealing device with microwave antenna
US6475182B1 (en) 1997-03-12 2002-11-05 Olexander Hnojewyj Fluidic media introduction apparatus
US20040176801A1 (en) * 1997-03-12 2004-09-09 Neomend, Inc. Pretreatment method for enhancing tissue adhesion
WO1998057678A2 (en) * 1997-06-18 1998-12-23 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar collagen
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
CA2319447C (en) * 1998-12-01 2010-01-26 Washington University Embolization device
US8882850B2 (en) * 1998-12-01 2014-11-11 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US6361551B1 (en) 1998-12-11 2002-03-26 C. R. Bard, Inc. Collagen hemostatic fibers
US6454787B1 (en) * 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
US7094428B2 (en) * 2000-06-16 2006-08-22 The University Of Medicine And Dentistry Of New Jersey Hemostatic compositions, devices and methods
US20020114795A1 (en) * 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
NZ527014A (en) * 2001-01-04 2005-06-24 Osteotech Inc Method for sterilizing bioactive materials by irradiating in the presence of hydrogen gas
US20030211793A1 (en) * 2001-03-05 2003-11-13 Eugene Bell Injectable bio-compatible material and methods of use
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
EP1458425B1 (en) 2001-12-21 2009-11-18 Ferrosan A/S A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
US7955288B2 (en) * 2002-12-11 2011-06-07 Ferrosan Medical Devices A/S Gelatine-based materials as swabs
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US8440225B2 (en) * 2003-08-07 2013-05-14 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US20060019868A1 (en) * 2004-01-30 2006-01-26 Pendharkar Sanyog M Hemostatic compositions and devices
CA2554994C (en) * 2004-01-30 2015-05-19 Ferrosan A/S Haemostatic sprays and compositions
KR20050086324A (ko) * 2004-02-25 2005-08-30 김아란 3%부터 9%까지 셀라인 (염수)
US8119160B2 (en) 2004-06-29 2012-02-21 Ethicon, Inc. Hemostatic compositions and devices
KR20070046093A (ko) * 2004-07-09 2007-05-02 훼로산 아크티에 셀스카브 히알루론산을 포함하는 지혈 조성물
GB2409162B (en) * 2004-10-06 2005-12-14 Bhk Holding Ltd Materials,methods,and apparatus for treating a body cavity
US20080220053A1 (en) * 2004-12-14 2008-09-11 Fidia Advanced Biopolymers S.R.L. Process for the Preparation of Two and Three Dimensional Polymer Scaffolds
MX2008014847A (es) * 2006-05-31 2009-04-30 Baxter Int Metodo para crecimiento interno en la celula dirigido y regeneracion controlada de los tejidos en la cirugia espinal.
US20080004431A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic Inc Method of manufacturing an injectable collagen material
TWI436793B (zh) * 2006-08-02 2014-05-11 巴克斯特國際公司 快速作用之乾密封膠及其使用和製造方法
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
ES2662647T3 (es) 2007-10-30 2018-04-09 Baxter International Inc. Uso de una biomatriz de colágeno biofuncional regenerativa para tratar defectos viscerales o parietales
CA2716872C (en) * 2008-02-29 2015-02-10 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US8840913B2 (en) * 2008-03-27 2014-09-23 Warsaw Orthopedic, Inc. Malleable multi-component implants and materials therefor
CA2716010C (en) * 2008-04-03 2019-10-01 Zymogenetics, Inc. Hemostatic microspheres
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
US9039783B2 (en) * 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
HRP20150255T1 (hr) * 2009-06-16 2015-05-08 Baxter International Inc. Hemostatiäśna spužva
US9629913B2 (en) * 2009-07-21 2017-04-25 Aidance Skincare And Topical Solutions, Llc Silver oxide formulations
GB2487773B (en) * 2011-02-04 2014-09-17 Aidance Skincare & Topical Solutions Llc Topical antibiotic formulations
US8652509B2 (en) * 2009-11-02 2014-02-18 Moshe Rogosnitzky Method of wound hemostasis using liquid gallium nitrate
US8771258B2 (en) * 2009-12-16 2014-07-08 Baxter International Inc. Hemostatic sponge
WO2011113436A1 (en) 2010-03-15 2011-09-22 Ferrosan Medical Devices A/S A method for promotion of hemostasis and/or wound healing
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
AU2011260260B2 (en) 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
ES2682302T3 (es) 2010-06-01 2018-09-19 Baxter International Inc Proceso para la producción de composiciones hemostáticas secas y estables
JP5973997B2 (ja) 2010-06-01 2016-08-23 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 乾燥した安定な止血用組成物を作製するためのプロセス
US8613938B2 (en) 2010-11-15 2013-12-24 Zimmer Orthobiologics, Inc. Bone void fillers
US10022410B2 (en) * 2010-12-22 2018-07-17 Ethicon, Inc. Hemostatic preparation containing an extract of golden moss
WO2012122044A2 (en) 2011-03-04 2012-09-13 Orthovita, Inc. Flowable collagen-based hemostat and methods of use
MX346958B (es) 2011-10-11 2017-04-06 Baxter Int Composición hemostatica.
WO2013053759A2 (en) 2011-10-11 2013-04-18 Baxter International Inc. Hemostatic compositions
SG11201401878SA (en) 2011-10-27 2014-09-26 Baxter Int Hemostatic compositions
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
KR101649450B1 (ko) * 2015-08-19 2016-08-18 이상철 피부 상처 치료조성물
HUE055368T2 (hu) 2016-08-12 2021-11-29 Biomup France Sas Vérzéscsillapító folyadék
US11464888B2 (en) 2017-06-12 2022-10-11 Warsaw Orthopedic, Inc. Moldable formulations containing an oxysterol in an acellular tissue matrix
US11007299B2 (en) * 2017-11-08 2021-05-18 Ethicon, Inc. Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery
EP3752211B1 (en) 2018-02-15 2023-12-27 Dilon Technologies Inc. Multi-dimensional hemostatic product and method for producing the same
EP4321182A3 (en) 2018-05-09 2024-05-29 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
CN109674496B (zh) * 2018-08-01 2019-11-15 浙江三创生物科技有限公司 输送药剂的器件及其装置和组件
KR102093839B1 (ko) * 2019-05-28 2020-05-04 (주)다림티센 지혈용 조성물 및 이를 포함하는 용기
US12285540B2 (en) 2020-07-21 2025-04-29 Ethicon, Inc. Hemostatic composite aggregate materials having surface enriched with hemostatis-promoting agents
WO2023004359A2 (en) 2021-07-21 2023-01-26 Organogenesis Inc. Porcine collagen compositions and methods of use thereof
US20230047711A1 (en) * 2021-08-13 2023-02-16 Sasan Najibi Flowable collagen colloid and method of forming
US20230079760A1 (en) * 2021-09-13 2023-03-16 Medtronic Inc. Surgical system and methods of use
CN114288463B (zh) * 2021-12-13 2022-07-05 鹏拓生物科技(杭州)有限公司 一种流体胶原蛋白止血材料的研制方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2579367A (en) * 1950-11-24 1951-12-18 Hynson Westcott & Dunning Inc Bandage
US3742955A (en) * 1970-09-29 1973-07-03 Fmc Corp Fibrous collagen derived product having hemostatic and wound binding properties
JPS5837330B2 (ja) * 1975-05-01 1983-08-16 カブシキガイシヤ ニツピ シケツヨウコラ−ゲンフンマツノセイゾウホウホウ
GB1584080A (en) * 1977-12-05 1981-02-04 Ethicon Inc Absorbable hemostatic composition
US4215200A (en) * 1978-10-02 1980-07-29 Cornell Research Foundation, Inc. Chemically and enzymatically modified collagen hemostatic agent
US4374830A (en) * 1979-10-04 1983-02-22 Research Corp. Platelet aggregating material from equine arterial tissue
DE2943520C2 (de) * 1979-10-27 1982-05-19 Fa. Carl Freudenberg, 6940 Weinheim Verfahren zur Herstellung von Kollagenschwamm für medizinische oder kosmetische Zwecke
DE3175003D1 (en) * 1981-06-25 1986-08-28 Serapharm Gmbh & Co Kg Enriched plasma derivative for promoting wound sealing and wound healing
JPS6144825A (ja) * 1984-08-09 1986-03-04 Unitika Ltd 止血剤
US4696812A (en) * 1985-10-28 1987-09-29 Warner-Lambert Company Thrombin preparations
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen

Also Published As

Publication number Publication date
DE68914110T2 (de) 1994-07-07
US4891359A (en) 1990-01-02
CA2004739A1 (en) 1990-06-08
IE62927B1 (en) 1995-03-08
CA2004739C (en) 2000-03-28
AU623456B2 (en) 1992-05-14
DE68914110D1 (de) 1994-04-28
JP3195335B2 (ja) 2001-08-06
EP0372966A3 (en) 1990-12-27
EP0372966B1 (en) 1994-03-23
ATE103187T1 (de) 1994-04-15
ZA899372B (en) 1991-08-28
AU4603789A (en) 1990-06-14
JPH02218616A (ja) 1990-08-31
IE893928L (en) 1990-06-08
EP0372966A2 (en) 1990-06-13

Similar Documents

Publication Publication Date Title
ES2062041T3 (es) Composicion hemostatica de pasta de colageno.
US4735660A (en) Cross-linked gel modeling composition
IL62424A (en) Mucopolysaccharide mixtures obtained by the depolymerisation of heparin,their preparation and pharmaceutical compositions containing them
ATE24838T1 (de) Lyophilisierte zusammensetzungen, ihre herstellung und verwendung.
ES8504449A1 (es) Procedimiento mejorado para la obtencion de un medio para el cuidado de la piel
SE8601522D0 (sv) Dental cement compositions
ATE57616T1 (de) Material zum ausfuellen von periodontalen knochendefekten.
HK59681A (en) Pharmaceutical compositions for use in the suppression of gastric reflux
NO173020C (no) Fremgangsmaate for fremstilling av en hydrokolloidblanding
DK173883D0 (da) Substituerede 8-phenylxanthiner
ATE154011T1 (de) Inhibitoren der calciumaufnahme
ES2188763T3 (es) Factor del tipo relaxina y metodos y usos del mismo.
FI830075A7 (fi) Polymeerikoostumuksia ja niiden käyttö liima-aineina tai liima- aineissa ja muissa koostumuksissa.
SE8303696D0 (sv) Farmakologiska kompositioner
IL64292A0 (en) D-homosteroids,their manufacture and pharmaceutical compositions containing them
JPS5432638A (en) Cosmetic base composition
ATE45286T1 (de) Gammainterferon und lymphotoxin enthaltende synergistische zusammensetzung und ihre herstellung.
DE59205662D1 (de) Alginat-Abformmasse
AR246274A1 (es) Polvo absorbible para espolvorear derivado de almidon.
EP0286601A3 (en) Powdered deodorant composition for shoes, in particular for sporting shoes
DE69112747D1 (de) Inhibitoren der Calciumaufnahme.
DE2961728D1 (en) Novel 2,6-dinitrobenzenamines, their preparation, composition containing them and their use as fungicides
EP0115278A3 (en) Use of 1-cyclopentenylacetic acid as perfuming ingredient, perfuming composition containing it and method to improve the odour of perfuming compositions and perfumed products
ES498864A0 (es) Perfeccionamientos en la preparacion de composiciones termo-genas
ES8500928A1 (es) Procedimiento para la obtencion de oxaspirododecan-derivados de efecto perfumante

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 372966

Country of ref document: ES